Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn E Stephenson

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|June 15, 2023
Live-attenuated Chikungunya vaccine: a possible new eraKathryn E Stephenson
The Lancet. Infectious Diseases|June 16, 2022
Novel chikungunya vaccine shows promise for durable protectionKathryn E Stephenson
Infectious Disease Clinics of North America|March 16, 2025
Next-Generation Coronavirus Disease 2019 Vaccines: Clinical Data and Future DirectionsKathryn E Stephenson
Current Opinion in HIV and AIDS|June 30, 2018
Therapeutic vaccination for HIV: hopes and challengesKathryn E Stephenson
Vaccines|September 28, 2024
HIV Vaccine Development at a Crossroads: New B and T Cell ApproachesRamesh Govindan, Kathryn E Stephenson
Immunological Reviews|June 19, 2013
A global approach to HIV-1 vaccine developmentKathryn E Stephenson, Dan H Barouch
Current HIV/AIDS Reports|February 5, 2016
Broadly Neutralizing Antibodies for HIV EradicationKathryn E Stephenson, Dan H Barouch
Nature Reviews. Microbiology|June 21, 2018
Zika virus vaccinesPeter Abbink, Kathryn E Stephenson, Dan H Barouch
Current Opinion in Immunology|June 9, 2016
New concepts in HIV-1 vaccine developmentKathryn E Stephenson, Helen T D'Couto, Dan H Barouch
Annual Review of Immunology|April 29, 2020
Vaccines and Broadly Neutralizing Antibodies for HIV-1 PreventionKathryn E Stephenson, Kshitij Wagh, Bette Korber, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|June 15, 2023
Live-attenuated Chikungunya vaccine: a possible new eraKathryn E Stephenson
The Lancet. Infectious Diseases|June 16, 2022
Novel chikungunya vaccine shows promise for durable protectionKathryn E Stephenson
Infectious Disease Clinics of North America|March 16, 2025
Next-Generation Coronavirus Disease 2019 Vaccines: Clinical Data and Future DirectionsKathryn E Stephenson
Current Opinion in HIV and AIDS|June 30, 2018
Therapeutic vaccination for HIV: hopes and challengesKathryn E Stephenson
Vaccines|September 28, 2024
HIV Vaccine Development at a Crossroads: New B and T Cell ApproachesRamesh Govindan, Kathryn E Stephenson
Immunological Reviews|June 19, 2013
A global approach to HIV-1 vaccine developmentKathryn E Stephenson, Dan H Barouch
Current HIV/AIDS Reports|February 5, 2016
Broadly Neutralizing Antibodies for HIV EradicationKathryn E Stephenson, Dan H Barouch
Nature Reviews. Microbiology|June 21, 2018
Zika virus vaccinesPeter Abbink, Kathryn E Stephenson, Dan H Barouch
Current Opinion in Immunology|June 9, 2016
New concepts in HIV-1 vaccine developmentKathryn E Stephenson, Helen T D'Couto, Dan H Barouch
Annual Review of Immunology|April 29, 2020
Vaccines and Broadly Neutralizing Antibodies for HIV-1 PreventionKathryn E Stephenson, Kshitij Wagh, Bette Korber, et al.
Pageof 7